TESTIM (TESTOSTERONE)
- Androgen deficiency
- Gonadotropin releasing factor deficiency
- Male hypogonadism
- Bilateral anorchia
- Bilateral orchiectomy
- Chemotherapy-induced hypogonadism
- Cryptorchidism
- Klinefelter's syndrome
- Primary hypogonadism due to bilateral torsion of testes
- Primary hypogonadism due to orchitis
50 mg/5 gram (1 %) transdermal gel
- Apply 50 mg (1 tube = 50 mg) by transdermal route once daily in the morning to shoulders and/or upper arms divided evenly between areas
50 mg/5 gram (1 %) transdermal gel
- Apply 50 mg (1 tube = 50 mg) by transdermal route once daily in the morning to shoulders and/or upper arms divided evenly between areas
50 mg/5 gram (1 %) transdermal gel
- Apply 50 mg (1 tube = 50 mg) by transdermal route once daily in the morning to shoulders and/or upper arms divided evenly between areas
Androgen deficiency
- Apply 50 mg (1 tube = 50 mg) by transdermal route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 50 mg (1 tube = 50 mg) by topical route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 100 mg (2 tubes = 100 mg) by topical route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 100 mg (2 tubes = 100 mg) by transdermal route once daily in the morning to shoulders and/or upper arms divided evenly between areas
Bilateral anorchia
- Apply 50 mg (1 tube = 50 mg) by transdermal route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 50 mg (1 tube = 50 mg) by topical route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 100 mg (2 tubes = 100 mg) by topical route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 100 mg (2 tubes = 100 mg) by transdermal route once daily in the morning to shoulders and/or upper arms divided evenly between areas
Bilateral orchiectomy
- Apply 50 mg (1 tube = 50 mg) by transdermal route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 50 mg (1 tube = 50 mg) by topical route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 100 mg (2 tubes = 100 mg) by topical route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 100 mg (2 tubes = 100 mg) by transdermal route once daily in the morning to shoulders and/or upper arms divided evenly between areas
Chemotherapy-induced hypogonadism
- Apply 50 mg (1 tube = 50 mg) by transdermal route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 50 mg (1 tube = 50 mg) by topical route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 100 mg (2 tubes = 100 mg) by topical route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 100 mg (2 tubes = 100 mg) by transdermal route once daily in the morning to shoulders and/or upper arms divided evenly between areas
Cryptorchidism
- Apply 50 mg (1 tube = 50 mg) by transdermal route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 50 mg (1 tube = 50 mg) by topical route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 100 mg (2 tubes = 100 mg) by topical route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 100 mg (2 tubes = 100 mg) by transdermal route once daily in the morning to shoulders and/or upper arms divided evenly between areas
Gonadotropin releasing factor deficiency
- Apply 50 mg (1 tube = 50 mg) by transdermal route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 50 mg (1 tube = 50 mg) by topical route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 100 mg (2 tubes = 100 mg) by topical route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 100 mg (2 tubes = 100 mg) by transdermal route once daily in the morning to shoulders and/or upper arms divided evenly between areas
Klinefelter's syndrome
- Apply 50 mg (1 tube = 50 mg) by transdermal route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 50 mg (1 tube = 50 mg) by topical route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 100 mg (2 tubes = 100 mg) by topical route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 100 mg (2 tubes = 100 mg) by transdermal route once daily in the morning to shoulders and/or upper arms divided evenly between areas
Male hypogonadism
- Apply 50 mg (1 tube = 50 mg) by transdermal route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 50 mg (1 tube = 50 mg) by topical route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 100 mg (2 tubes = 100 mg) by topical route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 100 mg (2 tubes = 100 mg) by transdermal route once daily in the morning to shoulders and/or upper arms divided evenly between areas
Primary hypogonadism due to bilateral torsion of testes
- Apply 50 mg (1 tube = 50 mg) by transdermal route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 50 mg (1 tube = 50 mg) by topical route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 100 mg (2 tubes = 100 mg) by topical route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 100 mg (2 tubes = 100 mg) by transdermal route once daily in the morning to shoulders and/or upper arms divided evenly between areas
Primary hypogonadism due to orchitis
- Apply 50 mg (1 tube = 50 mg) by transdermal route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 50 mg (1 tube = 50 mg) by topical route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 100 mg (2 tubes = 100 mg) by topical route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- Apply 100 mg (2 tubes = 100 mg) by transdermal route once daily in the morning to shoulders and/or upper arms divided evenly between areas
- None
Contraindicated
- None
Severe
Moderate
- None
- Lactating mother
- Malignant tumor of male breast
- Pregnancy
- Prostatic carcinoma
Contraindicated
- Acute myocardial infarction
- Benign prostatic hyperplasia
- Cerebrovascular accident
- Chronic pulmonary disease
- Erythrocytosis
- Hypercholesterolemia
- Kidney disease with reduction in GFR
- Polycythemia vera
- Pulmonary thromboembolism
- Venous thrombosis
Severe
Moderate
- Chronic heart failure
- Diabetes mellitus
- Disease of liver
- Edema
- Gynecomastia
- Humoral hypercalcemia of malignancy
- Hypertension
- Obesity
- Sleep apnea
TESTIM (TESTOSTERONE)
- Androgen deficiency
- Gonadotropin releasing factor deficiency
- Male hypogonadism
- Bilateral anorchia
- Bilateral orchiectomy
- Chemotherapy-induced hypogonadism
- Cryptorchidism
- Klinefelter's syndrome
- Primary hypogonadism due to bilateral torsion of testes
- Primary hypogonadism due to orchitis
- Gynecomastia
- Priapism
- Virilism
- Menstrual disorder
- Skin irritation
More Frequent
Severe
Less Severe
- Anemia
- Benign prostatic hyperplasia
- Disease of liver
- Dizziness
- Edema
- Epididymitis
- Headache disorder
- Hypercalcemia
- Mastalgia
- Mood changes
- Nausea
- Prostatic carcinoma
- Vomiting
- Acne vulgaris
- Body fluid retention
- Contact dermatitis
- Dream disorder
- Dysgeusia
- Flu-like symptoms
- General weakness
- Hypertension
- Increased pubic hair
- Insomnia
- Libido changes
- Malaise
- Nervousness
- Pruritus of skin
- Skin swelling
- Testicular atrophy
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Acute myocardial infarction
- Cerebrovascular accident
- Cholestatic hepatitis
- Deep venous thrombosis
- Depression
- Drug-induced hepatitis
- Erythrocytosis
- Heart failure
- Hepatic necrosis
- Jaundice
- Malignant neoplasm of liver
- Neoplasm of liver
- Peliosis hepatis
- Pulmonary thromboembolism
- Venous thrombosis
Less Severe
- Aggressive behavior
- Alopecia
- Anorexia
- Azoospermia
- Dry skin
- Dyspnea
- Fatigue
- Hair bleaching
- Hair discoloration
- Hirsutism
- Hostility
- Hyperhidrosis
- Hyperlipidemia
- Hypoglycemic disorder
- Increased libido
- Irritability
- Memory impairment
- Nocturia
- Oligospermia
- Paresthesia
- Peripheral edema
- Sleep apnea
- Symptoms of anxiety
- Testicular pain
- Urinary hesitancy
- Urinary incontinence
- Urinary retention
- Urinary urgency
- Vasodilation of blood vessels
- Weight gain
Contraindicated
None
Severe Precaution
Testosterone (Misc. Route)
Use may not be appropriate <18 years. May cause premature epiphyseal closure.
- 1 Day – 18 Years
- Use may not be appropriate <18 years. May cause premature epiphyseal closure.
Management or Monitoring Precaution
None
Testosterone
- Severity Level:
1
- Additional Notes: Androgens contraindicated in pregnancy; risk of virilization of female fetus.
Contraindicated
Testosterone
Poss sev adv effects, premature epiphyseal closure, virilization of females
General | Excretion Potential | Effect on Infant | Notes |
Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Poss sev adv effects, premature epiphyseal closure, virilization of females |
Precaution Exists
None
General | Excretion Potential | Effect on Infant | Notes |
None |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
Testosterone
General-Avoid use in the elderly unless indicated for confirmed hypogonadism. Urogenital-Increased risk of acute kidney injury. May exacerbate prostate cancer. Cardiovascular-Reports of venous thromboembolism, deep vein thrombosis and pulmonary embolism. Possible increased risk of atrial fibrillation.
Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
Increased Risk / Adverse Effects | N | N | Y | N | N | N |
BEERS: Y HEDIS: N STOPP: Y
No Known Risk
None
- Children accidentally exposed to this medication by direct contact with someone using it may absorb this drug through their skin. If this occurs, the child may have unwanted side effects due to testosterone gel. Children should avoid contact with the unwashed or unclothed area where the medication has been applied.<br /><br />Tell both of your doctors right away if you notice unexpected signs of puberty in a child such as unusual increase in size of genitals (penis or clitoris), early development of pubic hair, increased erections (in boys) or sex drive, or aggressive behavior. To decrease this risk, carefully follow all directions for the proper use of this drug.
Androgen deficiency | |
E29.1 | Testicular hypofunction |
Bilateral anorchia | |
Q55.0 | Absence and aplasia of testis |
Chemotherapy-induced hypogonadism | |
E29.1 | Testicular hypofunction |
Cryptorchidism | |
Q53 | Undescended and ectopic testicle |
Q53.0 | Ectopic testis |
Q53.00 | Ectopic testis, unspecified |
Q53.01 | Ectopic testis, unilateral |
Q53.02 | Ectopic testes, bilateral |
Q53.1 | Undescended testicle, unilateral |
Q53.10 | Unspecified undescended testicle, unilateral |
Q53.11 | Abdominal testis, unilateral |
Q53.111 | Unilateral intraabdominal testis |
Q53.112 | Unilateral inguinal testis |
Q53.12 | Ectopic perineal testis, unilateral |
Q53.13 | Unilateral high scrotal testis |
Q53.2 | Undescended testicle, bilateral |
Q53.20 | Undescended testicle, unspecified, bilateral |
Q53.21 | Abdominal testis, bilateral |
Q53.211 | Bilateral intraabdominal testes |
Q53.212 | Bilateral inguinal testes |
Q53.22 | Ectopic perineal testis, bilateral |
Q53.23 | Bilateral high scrotal testes |
Q53.9 | Undescended testicle, unspecified |
R39.83 | Unilateral non-palpable testicle |
R39.84 | Bilateral non-palpable testicles |
Gonadotropin releasing factor deficiency | |
E23.3 | Hypothalamic dysfunction, not elsewhere classified |
Klinefelter's syndrome | |
Q98.0 | Klinefelter syndrome karyotype 47, XXY |
Q98.1 | Klinefelter syndrome, male with more than two X chromosomes |
Q98.4 | Klinefelter syndrome, unspecified |
Male hypogonadism | |
E29.1 | Testicular hypofunction |
Primary hypogonadism due to bilateral torsion of testes | |
E29.1 | Testicular hypofunction |
Primary hypogonadism due to orchitis | |
E29.1 | Testicular hypofunction |
0-9 | A-Z |
---|---|
E23.3 | Hypothalamic dysfunction, not elsewhere classified |
E29.1 | Testicular hypofunction |
E29.1 | Testicular hypofunction |
E29.1 | Testicular hypofunction |
E29.1 | Testicular hypofunction |
E29.1 | Testicular hypofunction |
Q53 | Undescended and ectopic testicle |
Q53.0 | Ectopic testis |
Q53.00 | Ectopic testis, unspecified |
Q53.01 | Ectopic testis, unilateral |
Q53.02 | Ectopic testes, bilateral |
Q53.1 | Undescended testicle, unilateral |
Q53.10 | Unspecified undescended testicle, unilateral |
Q53.11 | Abdominal testis, unilateral |
Q53.111 | Unilateral intraabdominal testis |
Q53.112 | Unilateral inguinal testis |
Q53.12 | Ectopic perineal testis, unilateral |
Q53.13 | Unilateral high scrotal testis |
Q53.2 | Undescended testicle, bilateral |
Q53.20 | Undescended testicle, unspecified, bilateral |
Q53.21 | Abdominal testis, bilateral |
Q53.211 | Bilateral intraabdominal testes |
Q53.212 | Bilateral inguinal testes |
Q53.22 | Ectopic perineal testis, bilateral |
Q53.23 | Bilateral high scrotal testes |
Q53.9 | Undescended testicle, unspecified |
Q55.0 | Absence and aplasia of testis |
Q98.0 | Klinefelter syndrome karyotype 47, XXY |
Q98.1 | Klinefelter syndrome, male with more than two X chromosomes |
Q98.4 | Klinefelter syndrome, unspecified |
R39.83 | Unilateral non-palpable testicle |
R39.84 | Bilateral non-palpable testicles |